The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Apolipoprotein E polymorphism and atherosclerosis.
Abstract
The apo E locus contributes to determining the variation in plasma cholesterol levels of healthy and diseased populations. It also influences the expression of hyperlipidemia and appears to modulate the susceptibility to atherosclerosis in a complex multifactorial interaction. There is evidence that the presence of apo E2 is protective, whereas that of apo E4 predisposes to coronary artery disease. The burden of proof, however, lies on future, well-designed clinical trials and prospective studies. The study of the biological significance of the apo E polymorphism in humans has emphasized the importance of gene-gene and gene-environment interactions in the pathogenesis of hyperlipidemia and atherosclerosis. The apo E polymorphism involves the coding region of the apo E gene and results in alterations of the gene product which, in turn, either directly or secondarily affect the metabolic fate of the lipoprotein particles. Rapid advances in knowledge over the last decade have provided a metabolic explanation for the observation of the opposite effects of the epsilon 4 and the epsilon 2 alleles on lipoprotein levels. Apo E2 has lower receptor binding affinity which results in delayed clearance of apo E2-bearing lipoprotein particles from plasma. Apo E4 is distributed differently from apo E3 between VLDL and HDL, is degraded more rapidly than apo E3, and may enhance the catabolism of E4-bearing particles, leading to other alterations in lipoprotein metabolism which result in elevated levels of LDL. In view of the significant opposite impacts of the epsilon 4 and the epsilon 2 alleles on plasma LDL cholesterol concentrations, it is evident that determination of the apo E phenotype will become a useful adjunct to the assessment of the cardiovascular risk profile of an individual. In addition, the relationship between the epsilon 2 allele and type III hyperlipoproteinemia provides a valuable model for the study of complex genetic interactions in the pathogenesis of hyperlipidemia. The further study of apo E and its interactions shows great promise for a deeper comprehension of the pathogenesis of atherosclerosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The critical role of APOE in lipid metabolism is underscored by evidence showing that APOE2 homozygosity can lead to Hyperlipoproteinemia type III (HLP), characterized by mixed hypercholesterolemia and hypertriglyceridemia [35–39].”
In the citing paper
“This observation, coupled with evident mixed hypercholesterolemia and hypertriglyceridemia, supports the characterization of APOE2hAβ rats as a model for type III HLP”
In the citing paper
“Both the ε2 and the ε4 alleles are associated with unfavorable lipid profiles [8][9][10][11][12][13].”
From APOE and vascular disease: Sequencing and genotyping in general population cohorts (2023) · cites this paper as [13]
In the citing paper
“It is estimated that less than one in 20 individuals with the ε22 genotype will have overt type III hyperlipoproteinemia [24].”
From Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review (2016) · cites this paper as [24]
In the citing paper
“At the level of an individual the effect of the APOE polymorphism on plasma lipid levels is moderate, however since the APOE polymorphism is common, it contributes substantially to the total phenotypic variability in plasma lipid levels in the general population [21,24,58].”
From Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review (2016) · cites this paper as [24]
In the citing paper
“The pattern of associations between the six common APOE genotypes and plasma lipid levels is similar across populations, although the magnitude of the associations differs between populations and subgroups within populations; thus both context-dependent and invariant associations could be suggested [9,24,30].”
From Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review (2016) · cites this paper as [24]
In the citing paper
“Both ɛ2 and ɛ4 alleles are associated with unfavourable lipid profiles,12–19”
From Plasma levels of apolipoprotein E, APOE genotype, and all-cause and cause-specific mortality in 105 949 individuals from a white general population cohort (2019) · cites this paper as [18]
In the citing paper
“a decreased risk of coronary artery disease (unless it is associated with type III hyperlipoproteinemia), 42,43”
From Preclinical Evidence of Alzheimer's Disease in Persons Homozygous for the ε4 Allele for Apolipoprotein E (1996) · cites this paper as [42]
Citations
Cites
Boyles, J. K., Pitas, R. E., Wilson, E., Mahley, R. W., & Taylor, J. M. (1985) · Journal of Clinical Investigation · doi:10.1172/jci112130 · Cited by 829
Weisgraber, K. H., Rall, S. C., & Mahley, R. W. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52510-8 · Cited by 777
Lipoprotein receptors and cholesterol homeostasis
Mahley, R. W., & Innerarity, T. L. (1983) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(83)90001-1 · Cited by 756
Human apolipoprotein E. The complete amino acid sequence
Rall, S. C., Weisgraber, K. H., & Mahley, R. W. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34702-1 · Cited by 741
(1985) · PubMed · Cited by 706
Self-citationPolymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man
UTERMANN, G., HEES, M., & STEINMETZ, A. (1977) · Nature · doi:10.1038/269604a0 · Cited by 666
Zannis, V. I., & Breslow, J. L. (1981) · Biochemistry · doi:10.1021/bi00507a059 · Cited by 563
Polymorphism of apolipoprotein E
Utermann, G., Vogelberg, K. H., Steinmetz, A., Schoenborn, W., Pruin, N., Jaeschke, M., Hees, M. T. I. W. S.-V., & Canzler, H. (1979) · Clinical Genetics · doi:10.1111/j.1399-0004.1979.tb02027.x · Cited by 408
Apolipoprotein E polymorphism in health and disease
Utermann, G. (1987) · American Heart Journal · doi:10.1016/0002-8703(87)90610-7 · Cited by 389
Elshourbagy, N. A., Liao, W. S., Mahley, R. W., & Taylor, J. M. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.1.203 · Cited by 376
Cited by
Sorted by citations
Items 401–500 of 1,005
High Density Lipoprotein Inhibits Assembly of Amyloid β-Peptides into Fibrils
Olesen, O. F., & Dagø, L. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2372 · Cited by 76
Mann, W. A., Gregg, R. E., Sprecher, D. L., & Brewer, H. B. (1989) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(89)90043-x · Cited by 75
Self-citationPathophysiology of Lacunar Stroke: History's Mysteries and Modern Interpretations
Regenhardt, R. W., Das, A. S., Ohtomo, R., Lo, E. H., Ayata, C., & Gurol, M. E. (2019) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2019.05.006 · Cited by 76
Asada, T., Yamagata, Z., Kinoshita, T., Kinoshita, A., Kariya, T., Asaka, A., & Kakuma, T. (1996) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1996.tb02431.x · Cited by 75
Economou-Petersen, E., Aessopos, A., Kladi, A., Flevari, P., Karabatsos, F., Fragodimitri, C., Nicolaidis, P., Vrettou, H., Vassilopoulos, D., Karagiorga‐Lagana, M., et al. (1998) · Blood · doi:10.1182/blood.v92.9.3455 · Cited by 75
Terry, J. G., Howard, G., Mercuri, M. F., Bond, M. G., & Crouse, J. R. (1996) · Stroke · doi:10.1161/01.str.27.10.1755 · Cited by 75
Genetic influences on blood lipids and cardiovascular disease risk: tools for primary prevention
Ordovas, J. M. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.27113e · Cited by 74
Solanas-Barca, M., de Castro-Orós, I., Mateo-Gallego, R., Cofán, M., Plana, N., Puzo, J., Burillo, E., Martín-Fuentes, P., Ros, E., Masana, L., et al. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.03.011 · Cited by 74
Genetics of coronary heart disease: Current knowledge and research principles
Winkelmann, B. R., Hager, J., Kraus, W. E., Merlini, P. A., Keavney, B. D., Grant, P. J., Muhlestein, J. B., & Granger, C. B. (2000) · American Heart Journal · doi:10.1067/mhj.2000.109636 · Cited by 74
Nicoll, J. A. R., Burnett, C., Love, S., Graham, D. I., Ironside, J. W., & Vinters, H. V. (1996) · Annals of Neurology · doi:10.1002/ana.410390521 · Cited by 74
Lipidomics applications for disease biomarker discovery in mammal models
Zhao, Y., Cheng, X., Lin, R., & Wei, F. (2015) · Biomarkers in Medicine · doi:10.2217/bmm.14.81 · Cited by 74
Curti, M. L. R., Jacob, P., Borges, M. C., Rogero, M. M., & Ferreira, S. R. G. (2011) · Journal of Obesity · doi:10.1155/2011/497401 · Cited by 73
Li, H., Dhanasekaran, P., Alexander, E. T., Rader, D. J., Phillips, M. C., & Lund‐Katz, S. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.301193 · Cited by 73
Ojala, J.-P., Helve, E., Ehnholm, C., Aalto‐Setälä, K., KONTULA, K. K., & Tikkanen, M. J. (1991) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1991.tb00464.x · Cited by 73
The aging brain: The cognitive reserve hypothesis and hominid evolution
Allen, J. S., Bruss, J., & Damásio, H. (2005) · American Journal of Human Biology · doi:10.1002/ajhb.20439 · Cited by 72
Zweier, C., Temple, I. K., Beemer, F. A., Zackai, E., Lerman‐Sagie, T., Weschke, B., Anderson, C. E., & Rauch, A. M. (2003) · Journal of Medical Genetics · doi:10.1136/jmg.40.8.601 · Cited by 72
Unique character and metabolism of high density lipoprotein (HDL) in fetus
Nagasaka, H., Chiba, H., Kikuta, H., Akita, H., Takahashi, Y., Yanai, H., Hui, S.-P., Fuda, H., Fujiwara, H., & Kobayashi, K. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00663-3 · Cited by 72
Mahley, R. W., Pépin, J., Palaoğlu, K. E., Malloy, M. J., Kane, J. P., & Bersot, T. P. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33437-4 · Cited by 72
DNA-adducts and atherosclerosis: a study of accidental and sudden death males in the Czech Republic
Binková, B., Šmerhovský, Z., Strejc, P., Boubelík, O., Stávková, Z., Chvátalová, I., & Šrám, R. J. (2002) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(02)00019-2 · Cited by 72
Capurso, C. A., Solfrizzi, V., D’Introno, A., Colacicco, A. M., Capurso, S. A., Capurso, A., & Panza, F. (2004) · Experimental Gerontology · doi:10.1016/j.exger.2004.07.006 · Cited by 72
Xu, C., Boerwinkle, E., Tikkanen, M. J., Huttunen, J. K., Humphries, S. E., Talmud, P. J., & Rao, D. C. (1990) · Genetic Epidemiology · doi:10.1002/gepi.1370070405 · Cited by 72
Ionizing radiation and genetic risks
Sankaranarayanan, K., & Chakraborty, R. (2000) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(00)00106-8 · Cited by 72
Niederkofler, E. E., Tubbs, K. A., Kiernan, U. A., Nedelkov, D., & Nelson, R. W. (2003) · Journal of Lipid Research · doi:10.1194/jlr.d200034-jlr200 · Cited by 71
Apolipoprotein E type ϵ4 allele frequency is increased in patients with schizophrenia
Harringtonaa, C. R., Roth, M., Xuereb, J. H., McKenna, P. J., & Wischik, C. M. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)12218-4 · Cited by 71
Gómez‐Coronado, D., Álvarez, J. J., Bueno, A. E., Olmos, J. M., Herrera, E., & Lasunción, M. A. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00168-9 · Cited by 71
Reilly, S. L., Ferrell, R. E., & Sing, C. F. (1994) · PubMed Central · Cited by 71
Self-citationJi, Y., Urakami, K., Adachi, Y., Maeda, M., Isoe, K., & Nakashima, K. (1998) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017068 · Cited by 70
Apolipoprotein E genotypes and age of onset in early‐onset familial Alzheimer's disease
Levy‐Lahad, E., Lahad, A., Wijsman, E. M., Bird, T. D., & Schellenberg, G. D. (1995) · Annals of Neurology · doi:10.1002/ana.410380420 · Cited by 72
High frequency of the apo ?4 allele in Khoi San from South Africa
Sandholzer, C., Delport, R., Vermaak, H., & Utermann, G. (1995) · Human Genetics · doi:10.1007/bf00225073 · Cited by 70
BOCKXMEER, F. M. V., Mamotte, C. D. S., Gibbons, F. A., Burke, V., & Taylor, R. R. (1995) · Circulation · doi:10.1161/01.cir.92.8.2066 · Cited by 70
Syvänen, A.-C., Aalto‐Setälä, K., KONTULA, K. K., & Söderlund, H. (1989) · FEBS Letters · doi:10.1016/0014-5793(89)81618-7 · Cited by 70
High carbohydrate diets and Alzheimer's disease
Henderson, S. T. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2003.11.028 · Cited by 72
TAIMELA, S. P., Lehtimäki, T. J., Porkka, K. V. K., Räsänen, L., & Viikari, J. S. A. (1996) · Metabolism · doi:10.1016/s0026-0495(96)90149-3 · Cited by 69
Apolipoprotein E, cardiovascular disease and cognitive function in aging women
Kang, J. H., Logroscino, G., Vivo, I. D., Hunter, D., & Grodstein, F. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.05.003 · Cited by 70
Prospective Study of Apolipoprotein E Genotype and Functional Outcome Following Ischemic Stroke
McCarron, M. O., Muir, K. W., Nicoll, J. A. R., Stewart, J., Currie, Y., Brown, K., & Bone, I. (2000) · Archives of Neurology · doi:10.1001/archneur.57.10.1480 · Cited by 69
Population Genetics of CAPN10 and GPR35: Implications for the Evolution of Type 2 Diabetes Variants
Molen, J. E. V., Frisse, L. M., Fullerton, S. M., Qian, Y., del Bosque‐Plata, L., Hudson, R. R., & Rienzo, A. D. (2005) · The American Journal of Human Genetics · doi:10.1086/428784 · Cited by 71
The apolipoprotein E polymorphism in Greenland Inuit in its global perspective
Gerdes, L. U., Gerdes, C., HANSEN, P. S., Klausen, I. C., Færgeman, O., & Dyerberg, J. (1996) · Human Genetics · doi:10.1007/s004390050257 · Cited by 69
Tsuang, D., Kukull, W., Sheppard, L., Barnhart, R. L., Peskind, E., Edland, S. D., Schellenberg, G., Raskind, M., & Larson, E. B. (1996) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1996.tb01836.x · Cited by 69
Relkin, N. R., Kwon, Y. J., Tsai, J., & Gandy, S. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb32608.x · Cited by 69
Molecular and biochemical changes of the cardiovascular system due to smoking exposure
Armani, C., Landini Jr., L., & Leone, A. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209787846973 · Cited by 68
Effect of the Apolipoprotein E ε4 Allele on White Matter Hyperintensities in Dementia
Hirono, N., Yasuda, M., Tanimukai, S., Kitagaki, H., & Mori, E. (2000) · Stroke · doi:10.1161/01.str.31.6.1263 · Cited by 68
Miettinen, H. E., Korpela, K., H�m�l�inen, L., & KONTULA, K. K. (1994) · Human Genetics · doi:10.1007/bf00202868 · Cited by 68
Srinivasan, S. R., & Berenson, G. S. (1995) · Clinical Chemistry · doi:10.1093/clinchem/41.1.159 · Cited by 68
Apolipoprotein E allele distribution in parents of Down's syndrome children
Avramopoulos, D., Grigoriadou, M., Petersen, M. B., Mikkelsen, M., Petersen, M. B., & Vassilopoulos, D. (1996) · The Lancet · doi:10.1016/s0140-6736(96)91346-x · Cited by 68
Crews, D. E. (2003) · Cambridge University Press eBooks · doi:10.1017/cbo9780511542350 · Cited by 69
Luoma, P. V., Näyhä, S., Sikkilä, K., & Hassi, J. (1995) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1995.tb01139.x · Cited by 69
Laakso, M., Kesäniemi, A., Kervinen, K., Jauhiainen, M., & Pyörälä, K. (1991) · BMJ · doi:10.1136/bmj.303.6811.1159 · Cited by 68
Bennett, C., Crawford, F., Osborne, A., Diaz, P., Hoyne, J., Lopez, R., Roques, P., Duara, R., Rossor, M., & Mullan, M. (1995) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320600102 · Cited by 67
Change in cognitive functioning associated with ApoE genotype in a community sample of older adults.
Hofer, S. M., Christensen, H. M., Mackinnon, A. J., Korten, A. E., Jorm, A. F., Henderson, A. S., & Easteal, S. (2002) · Psychology and Aging · doi:10.1037/0882-7974.17.2.194 · Cited by 71
Virtanen, J. K., Mursu, J., Virtanen, H. E., Fogelholm, M., Salonen, J. T., Koskinen, T. T., Voutilainen, S., & Tuomainen, T. (2016) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.115.122317 · Cited by 67
Plasma lipids, lipoproteins and post‐heparin lipases in ponies with hyperlipaemia
Watson, T. D. G., Burns, L., Love, S., Packard, C. J., & SHEPHERD, J. (1992) · Equine Veterinary Journal · doi:10.1111/j.2042-3306.1992.tb02852.x · Cited by 67
Gueguen, R., Visvikis‐Siest, S., Steinmetz, J., Siest, G., & Boerwinkle, E. (1989) · PubMed · Cited by 67
Apolipoprotein E, an important player in longevity and age-related diseases
Ang, L. S., Cruz, R. P., Hendel, A., & Granville, D. J. (2008) · Experimental Gerontology · doi:10.1016/j.exger.2008.03.010 · Cited by 70
Competition of Aβ amyloid peptide and apolipoprotein E for receptor-mediated endocytosis
Winkler, K., Scharnagl, H., Tisljar, U., Hoschützky, H., Friedrich, I., Hoffmann, M. M., Hüttinger, M., Wieland, H., & März, W. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32449-4 · Cited by 66
Fallaize, R., Celis-Morales, C. A., Macready, A. L., Marsaux, C. F. M., Forster, H., O’Donovan, C. B., Woolhead, C., San-Cristóbal, R., Kolossa, S., Hallmann, J., et al. (2016) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.116.135012 · Cited by 66
Age at onset of Parkinson disease and apolipoprotein E genotypes
Zareparsi, S., Camicioli, R. M., Sexton, G. J., Bird, T. D., Swanson, P. D., Kaye, J. A., Nutt, J. G., & Payami, H. (2001) · American Journal of Medical Genetics · doi:10.1002/ajmg.10111 · Cited by 66
Champagne, D. L., Pearson, D., Dea, D., Rochford, J. M., & Poirier, J. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00361-0 · Cited by 66
Gaddi, A. V., Ciarrocchi, A., Matteucci, A., Rimondi, S., Ravaglia, G., Descovich, G. C., & Sirtori, C. (1991) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/53.5.1191 · Cited by 66
Payami, H., Grimslid, H., Oken, B., Camicioli, R. M., Sexton, G. J., Dame, A., Howieson, D. B., & Kaye, J. A. (1997) · PubMed · Cited by 66
Niu, W., Qi, Y., Qian, Y., Gao, P., & Zhu, D. (2009) · Hypertension Research · doi:10.1038/hr.2009.164 · Cited by 65
Characterisation of single nucleotide polymorphisms in sugarcane ESTs
Cordeiro, G. M., Eliott, F. G., McIntyre, C. L., Casu, R. E., & Henry, R. J. (2006) · Theoretical and Applied Genetics · doi:10.1007/s00122-006-0300-8 · Cited by 65
Apolipoprotein E and central nervous system disorders: Reviews of clinical findings
Takeda, M., Martínez, R., Kudo, T., Tanaka, T., Okochi, M., Tagami, S., Morihara, T., Hashimoto, R., & Cacabelos, R. (2010) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2010.02148.x · Cited by 66
Alzheimer’s Disease Risk Genes and Lipid Regulators
Gaamouch, F. E., Jing, P., Xia, J., & Cai, D. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160169 · Cited by 67
The impact of EPA and DHA on blood lipids and lipoprotein metabolism: influence of apoE genotype
Anil, E. (2007) · Proceedings of The Nutrition Society · doi:10.1017/s0029665107005307 · Cited by 69
Sepehrnia, B., Kamboh, M. I., Adams-Campbell, L. L., Bunker, C. H., Nwankwo, M. U., Majumder, P. P., & Ferrell, R. E. (1989) · PubMed · Cited by 65
Rebeck, G. W., Alonzo, N. C., Berezovska, O., Harr, S. D., Knowles, R. B., Growdon, J. H., Hyman, B. T., & Mendez, A. J. (1998) · Experimental Neurology · doi:10.1006/exnr.1997.6710 · Cited by 66
Panza, F. (2003) · Experimental Gerontology · doi:10.1016/s0531-5565(03)00154-2 · Cited by 65
Plasma apolipoproteins in patients with multi-infarct dementia
Shimano, H., Ishibashi, S., Murase, T., Gotohda, T., Yamada, N., Takaku, F., & Ohtomo, E. (1989) · Atherosclerosis · doi:10.1016/0021-9150(89)90132-9 · Cited by 65
Laatsch, A., Panteli, M., Sornsakrin, M., Hoffzimmer, B., Grewal, T., & Heeren, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029385 · Cited by 67
Chang, M., Yesupriya, A., Ned, R. M., Mueller, P. W., & Dowling, N. F. (2010) · BMC Medical Genetics · doi:10.1186/1471-2350-11-62 · Cited by 65
Synergistic effects of APOE and sex on the gut microbiome of young EFAD transgenic mice
Weng, J. M., Parikh, I. J., Naqib, A. D., York, J. M., Green, S. J., Estus, S., & LaDu, M. J. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0352-2 · Cited by 65
Effect of apolipoprotein E genotype on in-hospital mortality following intracerebral haemorrhage
McCarron, M. O., Weir, C. J., Muir, K. W., Hoffmann, K. L., Graffagnino, C., Nicoll, J. A. R., Lees, K. R., & Alberts, M. J. (2003) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2003.01365.x · Cited by 64
Chasman, D. I., Kozłowski, P., Zee, R. Y. L., Kwiatkowski, D. J., & Ridker, P. M. (2006) · Genes and Immunity · doi:10.1038/sj.gene.6364289 · Cited by 65
Genetic aspects of susceptibility to obesity and related dyslipidemias
Després, J., Moorjani, S., Lupien, P.-J., Tremblay, A., Nadeau, A., & Bouchard, C. (1992) · Molecular and Cellular Biochemistry · doi:10.1007/bf00231535 · Cited by 65
Association of apolipoprotein (Apo)E genotype with plasma apo E levels
Larson, I. A., Ordovás, J. M., DeLuca, C., Barnard, J. R., Feussner, G., & Schaefer, E. J. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00280-4 · Cited by 64
Marais, A. D., Solomon, G. A. E., & Blom, D. J. (2014) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2013.870526 · Cited by 70
Molecular Mechanism of Apolipoprotein E Binding to Lipoprotein Particles
Nguyen, D., Dhanasekaran, P., Phillips, M. C., & Lund‐Katz, S. (2009) · Biochemistry · doi:10.1021/bi9000694 · Cited by 66
Salazar, L. A., Hirata, M. H., Giannini, S. D., Forti, N. A., Diament, J., de Lima, T. M., & Hirata, R. D. C. (2000) · Clinica Chimica Acta · doi:10.1016/s0009-8981(00)00308-9 · Cited by 63
Apolipoprotein E genetic polymorphism, serum lipoproteins, and breast cancer risk
Moysich, K. B., Freudenheim, J. L., Baker, J. A., Ambrosone, C. B., Bowman, E. D., Schisterman, E. F., Vena, J. E., & Shields, P. G. (2000) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(200001)27:1 · Cited by 63
Amyloid and lipids in the pathology of Alzheimer disease
Roher, A. E., Kuo, Y., Kokjohn, K., Emmerling, M. R., & Gracon, S. I. (1999) · Amyloid · doi:10.3109/13506129909007315 · Cited by 63
Kao, J., Tsai, K., Chang, C., & Huang, P. (1995) · Atherosclerosis · doi:10.1016/0021-9150(94)05464-t · Cited by 63
Hubacek, J. A., & Bobková, D. (2006) · Molecular Diagnosis & Therapy · doi:10.1007/bf03256448 · Cited by 63
Plasma Acylation-Stimulating Protein in Coronary Artery Disease
Cianflone, K., Zhang, X., Genest, J. J., & Sniderman, A. D. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvb.17v07.1239 · Cited by 63
Bergmann, M. M., Ebke, M., Yuan, Y., Brück, W., Mugler, M., & Schwendemann, G. (1996) · Acta Neuropathologica · doi:10.1007/s004010050528 · Cited by 63
Huang, Y., von Eckardstein, A., Wu, S., & Assmann, G. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118336 · Cited by 49
Keavney, B. D. (2004) · International Journal of Epidemiology · doi:10.1093/ije/dyh275 · Cited by 62
Lipoprotein Physiology and Its Relationship to Atherogenesis
Ginsberg, H. N. (1990) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30322-0 · Cited by 62
Boer, J. M. A., Ehnholm, C., Menzel, H., Havekes, L. M., Rosseneu, M., O’Reilly, D. S. J., Tiret, L., & for the EARS Group (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.9.1675 · Cited by 62
Inverse relation between Braak stage and cerebrovascular pathology in Alzheimer predominant dementia
Goulding, J. M. R., Signorini, D. F., Chatterjee, S., Nicoll, J. A. R., Stewart, J., Morris, R. G., & Lammie, G. A. (1999) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.67.5.654 · Cited by 62
Brown, A. J., & Roberts, D. C. K. (1991) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.11.6.1737 · Cited by 62
Kessling, A. M., Ouellette, S., Bouffard, O., Chamberland, A., Bétard, C., Selinger, E., Xhignesse, M., Lussier‐Cacan, S., & Davignon, J. (1992) · Europe PMC (PubMed Central) · Cited by 63
Self-citationLowering cholesterol, 1988. Rationale, mechanisms, and means.
Havel, R. J. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113501 · Cited by 62
Champagne, D. L., Dupuy, J.-B., Rochford, J. M., & Poirier, J. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00313-5 · Cited by 64
Caselli, R. J., Osborne, D., Reiman, E. M., Hentz, J. G., Barbieri, C. J., Saunders, A. M., Hardy, J., Graff‐Radford, N. R., Hall, G. R., & Alexander, G. E. (2001) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(01)00577-9 · Cited by 62
Genetic Factors for the Development of Alzheimer Disease in the Cherokee Indian
Rosenberg, R. N., RICHTER, R. W., Risser, R. C., Taubman, K. E., Prado-Farmer, I., Ebalo, E., Posey, J., Kingfisher, D., Dean, D., Weiner, M., et al. (1996) · Archives of Neurology · doi:10.1001/archneur.1996.00550100071017 · Cited by 61
Kolovou, G. D., Yiannakouris, N., Hatzivassiliou, M., Malakos, J. S., Daskalova, D. C., Hatzigeorgiou, G., Cariolou, M. A., & Cokkinos, D. V. (2002) · Current Medical Research and Opinion · doi:10.1185/030079902125000444 · Cited by 61
Ordovás, J. M., & Schaefer, E. J. (2000) · British Journal Of Nutrition · doi:10.1017/s0007114500001069 · Cited by 61
Bensen, J. T., Li, R., Hutchinson, R. G., Province, M. A., & Tyroler, H. A. (1999) · Genetic Epidemiology · doi:10.1002/(sici)1098-2272(1999)16:2 · Cited by 42
Sanllehy, C., Casals, E., Rodrı́guez-Villar, C., Zambón, D., Ojuel, J., Ballesta, A. M., & Ros, E. (1998) · Metabolism · doi:10.1016/s0026-0495(98)90240-2 · Cited by 62
HMG CoA Reductase Inhibitors (Statins): Do They Have a Role in Age-related Macular Degeneration?
Guymer, R. H., Chiu, A. W.-I., Lim, L. L., & Baird, P. N. (2005) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2004.12.002 · Cited by 61
Metadata
- Authors
- Davignon, J., Gregg, R. E., & Sing, C. F.
- Affiliations
- Montreal Clinical Research Institute (CA)
- Venue
- Arteriosclerosis: An Official Journal of the American Heart Association, Inc.
- Published
- 1988-01
- Volume
- 8
- Issue
- 1
- Pages
- 1-21
- ISSN
- 0276-5047 (ISSN-L)
- OpenAlex
- W2066644955
- Cited by
- 1,981
- References
- 98
- Citations by year
- 2026: 10 · 2025: 7 · 2024: 17 · 2023: 10 · 2022: 9 · 2021: 21 · 2020: 21 · 2019: 21 · 2018: 27 · 2017: 28 · 2016: 23 · 2015: 33 · 2014: 31 · 2013: 40 · 2012: 49
- FWCI
- 83.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Arteriosclerosis An Official Journal of the American Heart Association Inc (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (HL24489, HL-39107)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Keywords
- APOE polymorphism, atherosclerosis, coronary artery disease, hyperlipidemia, LDL cholesterol, lipoprotein metabolism, gene-environment interaction, type III hyperlipoproteinemia, cardiovascular risk assessment, genetic susceptibility
- MeSH terms
- Alleles, Apolipoproteins, Apolipoproteins E, Arteriosclerosis, Coronary Disease, Humans, Lipids, Lipoproteins, Phenotype, Polymorphism, Genetic, Radiography, Risk Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
